Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Ketamine Administered Intravenously and by Sublingual Wafer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01377831
Recruitment Status : Completed
First Posted : June 21, 2011
Last Update Posted : March 10, 2015
Sponsor:
Information provided by (Responsible Party):
iX Biopharma Ltd.

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Completed
Actual Primary Completion Date : June 2011
Actual Study Completion Date : June 2011
Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 March 26, 2015
April 7, 2015
2 March 28, 2016
April 27, 2016
3 September 7, 2016
October 27, 2016